NETopathic Inflammation in Chronic Obstructive Pulmonary Disease and Severe Asthma

by Mohib Uddin, Mohib Uddin, Henrik Watz, Henrik Watz, Anna Malmgren, Frauke Pedersen, Frauke Pedersen, Frauke Pedersen
Published 2019-02-01

Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone

by Beatrix Balint, Henrik Watz, Carolynn Amos, et al
Published 2010-09-01

A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD

by Dave Singh, Fernando J. Martinez, Henrik Watz, Thomas Bengtsson, Brian T. Maurer
Published 2020-02-01

Decline of COPD exacerbations in clinical trials over two decades – a systematic review and meta-regression

by Stefan Andreas, Christian Röver, Judith Heinz, Sebastian Straube, Henrik Watz, Tim Friede
Published 2019-08-01

Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study

by Lars Harbaum, Jan K. Hennigs, Marcel Simon, Tim Oqueka, Henrik Watz, Hans Klose
Published 2021-07-01

Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis

by Torsten Goldmann, Gernot Zissel, Henrik Watz, Daniel Drömann, Martin Reck, Christian Kugler, Klaus F. Rabe, Sebastian Marwitz
Published 2018-07-01

Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial

by Jutta Beier, Henrik Watz, Zuzana Diamant, Jens M. Hohlfeld, Dave Singh, Pascale Pinot, Ieuan Jones, Hanns-Christian Tillmann
Published 2021-04-01

e causes cellular trans-differentiation in human bronchial epithelia

by Michael Glöckner, Sebastian Marwitz, Kristina Rohmann, Henrik Watz, Dörte Nitschkowski, Jan Rupp, Klaus Dalhoff, Torsten Goldmann, Daniel Drömann
Published 2021-04-01

Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD – a retrospective analysis

by Rainer Gloeckl, Christoph Nell, Tessa Schneeberger, Inga Jarosch, Martina Boensch, Henrik Watz, Hubert Wirtz, Tobias Welte, Klaus Kenn, Andreas Rembert Koczulla
Published 2020-09-01

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial

by Henrik Watz, Kay Tetzlaff, Helgo Magnussen, Achim Mueller, Roberto Rodriguez-Roisin, Emiel F. M. Wouters, Claus Vogelmeier, Peter M. A. Calverley
Published 2018-12-01

CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial

by Aili L. Lazaar, Bruce E. Miller, Alison C. Donald, Thomas Keeley, Claire Ambery, John Russell, Henrik Watz, Ruth Tal-Singer, for 205724 Investigators
Published 2020-06-01

Exploration of the sputum methylome and omics deconvolution by quadratic programming in molecular profiling of asthma and COPD: the road to sputum omics 2.0

by Espen E. Groth, Melanie Weber, Thomas Bahmer, Frauke Pedersen, Anne Kirsten, Daniela Börnigen, Klaus F. Rabe, Henrik Watz, Ole Ammerpohl, Torsten Goldmann
Published 2020-10-01

The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD

by Henrik Watz, Felix Herth, Jens M Hohlfeld, Johannes Haas, Alberto de la Hoz, Xidong Jin, Karl-Friedrich Kreitner, Claus Vogelmeier, Jens Vogel-Claussen
Published 2020-05-01

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach

by Kathrin Kahnert, Peter Alter, Tobias Welte, Rudolf M. Huber, Jürgen Behr, Frank Biertz, Henrik Watz, Robert Bals, Claus F. Vogelmeier, Rudolf A. Jörres
Published 2018-06-01

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD

by Dave Singh, Kai Michael Beeh, Brendan Colgan, Oliver Kornmann, Brian Leaker, Henrik Watz, Germano Lucci, Silvia Geraci, Aida Emirova, Mirco Govoni, Marie Anna Nandeuil
Published 2019-08-01

Brain Activation during Perception and Anticipation of Dyspnea in Chronic Obstructive Pulmonary Disease

by Roland W. Esser, Maria C. Stoeckel, Anne Kirsten, Henrik Watz, Karin Taube, Kirsten Lehmann, Helgo Magnussen, Christian Büchel, Andreas von Leupoldt, Andreas von Leupoldt
Published 2017-08-01

Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis

by Thomas Bahmer, Anne-Marie Kirsten, Benjamin Waschki, Klaus F. Rabe, Helgo Magnussen, Detlef Kirsten, Marco Gramm, Simone Hummler, Eva Brunnemer, Michael Kreuter, Henrik Watz
Published 2017-07-01

Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over stud...

by Henrik Watz, Jens M. Hohlfeld, Dave Singh, Jutta Beier, Zuzana Diamant, Jinming Liu, Shucheng Hua, Khalid Abd-Elaziz, Pascale Pinot, Ieuan Jones, Hanns-Christian Tillmann
Published 2020-04-01

Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD

by Peter Alter, Henrik Watz, Kathrin Kahnert, Klaus F. Rabe, Frank Biertz, Ronald Fischer, Philip Jung, Jana Graf, Robert Bals, Claus F. Vogelmeier, Rudolf A. Jörres
Published 2019-03-01

Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study

by Mustafa Abdo, Henrik Watz, Vera Veith, Anne-Marie Kirsten, Heike Biller, Frauke Pedersen, Erika von Mutius, Matthias V. Kopp, Gesine Hansen, Benjamin Waschki, Klaus F. Rabe, Frederik Trinkmann, Thomas Bahmer
Published 2020-10-01